Top Markets
#1 Wibx Wibx +8.04%
#2 Status Status +7.32%
#3 Decred Decred +5.88%
#4 aelf aelf +5.13%
#5 Humanity Humanity +4.81%
#6 MarsCoin MarsCoin +3.34%
#7 TRIA TRIA +3.25%
#8 Rei Rei +2.83%
#9 Bless Bless +2.73%
#10 rsERG rsERG +2.41%
Coin of the day
Wibx Wibx
Settings
Language
ENGLISH
Currency
USD
Theme
Diffusion Pharmaceuticals Inc. Diffusion Pharmaceuticals Inc.

Diffusion Pharmaceuticals Inc.

DFFN
Rank in Stocks #31351
As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates... As a biopharmaceutical enterprise, Diffusion Pharmaceuticals Inc. concentrates on pioneering new treatments that bolster the body's efficiency in oxygen distribution. The company's flagship investigational therapy is Trans Sodium Crocetinate, which is formulated to facilitate the spread of oxygen into tissues. This compound is additionally under development for its application in addressing COVID-19. Headquartered in Charlottesville, Virginia, Diffusion Pharmaceuticals Inc. was established in 2001.
Share Price
$6.60
Last synced: 2023-08-16
Market Cap
$13.46M
Change (1 day)
11.68%
Change (1 year)
0.00%
Country
US
Trade Diffusion Pharmaceuticals Inc. (DFFN)

Category

Healthcare
Number of shares outstanding for Diffusion Pharmaceuticals Inc. (DFFN)
Number of shares outstanding as of August 2026: 0
According to Diffusion Pharmaceuticals Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Diffusion Pharmaceuticals Inc. (DFFN) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE